Adhesion Molecules. II: Interactions of Keratinocytes with Epidermal Basement Membrane  by Yancey, Kim B.
Abridged from the 
Dermatology 
Foundation Progress in Dermatology 
Editor: Alan N. Moshell , M.D. 
Adhesion Molecules. II: Interactions of 
Keratinocytes with Epidertnal Basetnent Metnbrane 
Kim B. Yancey 
Senior Investigator, Dermatology Branch, Nationa l Cancer Institute, National Institutes of H ealth, Bethesda, Mary land, U.S.A. 
I nterconnections between keratin intermediate filaments and hem idesmosomes in basal keratinocytes, anchoring fila-ments and macromolecules in lamina lucida, a network of structural proteins in lamina densa, and anchoring fibriJs and interstitiaJ collagen fibriJs in papillary dermis fonn a contin-
uo us unit that promotes adhesion of keratinocytes to epidermal 
basement membrane (BM) . A schematic diagram of thi s model is 
presented in Fig 1 and described in general tcrms below. T he 
predominant in termcdiate filaments in basal kcratinocytes are kc ra-
tins 14 and 5. These polypeptides, acidic and basic keratins, 
respectively, self- assemble as hetero dimcrs that in turn combine in 
anti parallel to form heterotetram ers . T he latter associate end to end 
and lateral ly to form 10-lml keratin intermcdiate fuaments that 
comprise part of the cytoskeleton of basal kcratinocytes. Keratin 
intennediate fuaments in basal keratinocytes insert into the electron 
dense plaques of desmosomes and hemidesmosomes. T he latte r are 
positioned in the basil ar region of these cclls just beside pl asm a 
membrane that immediately overlies the lamilla lucida of cpidermal 
BM. Hemidesmosom es contain bullous pcmphigoid antigen 1 
(BPAG1), buJlo us pemphigoid antigen 2 (BPAG2), integrin 0'6{3'I' 
and othe r molecules not yet completcly characterized. BPAG1 is a 
230-kD protein with striking sequence homology to desmoplakin 
III[ and plectin, proteins thought to bind intermcdiate fil aments. 
BPAG2 is a 180-kD transmembrane molecule in hcmidcsmosomes; 
it has collageno us scgments in its extraccllular dom ain . Integrin 
0'(,{34 is a ' transmembrane heterodimer th at like other integrins 
serves as a receptor for extracellular matrix m o lccu les. T he extra-
celJular domains of BPAG2 and 0'6{3" intcgrin extend into the 
lamina lucida of cpidermal BM at thc site where anchoring 
fiJaments are located. By electron microscopy, anchoring fi lam ents 
are visualized as threadlike structures that connect hemidesmo-
somes to the underlying lamina densa. Prote ins associated with 
anchoring fi lam ents include laminin 5 (a lso ca ll cd ka linin or nicei.n), 
laminin 6 (also callcd K-Iaminin), epiligrin , and uncein (a lso called 
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19-DEJ-l antigen) . At present it is not kll0wn whether anchOl'in g 
fiJaments inscrt in to the lamina dcnsa or pass through this network 
of structural proteins and bind directly to anchoring fibri ls ill the 
subl amina densa region. Other constituents of epidermal BM 
lamina lucida include Iaminill 1 and nidogen. Laminll 1 (also callcd 
"classical" or EHS-Iaminin) is a large (- 800 kD) heterotrimer 
composed of al , {31 , and 1'1 hlminin chains. Laminin 1 is a 
ubiqui tous component of epithelial BMs (but not BM in mu scle) . 
Nidogen (also ca lled en tactin) is a 1S0-kD protein that binds a 
specifIC domain in the )'1 chain of laminin (formerly called the B2 
or B2e chain of laminin), thus connectin g the lattcr matrix m o lc-
cule to type IV collagen in lamina den sa. Type IV collagen is a 
heterotrim eric protein that most fi'eqllently contains 0'1 and a2 
chains, though a3, a4, and as minor typc IV co llagcn chains c:Klst 
in selected tissues. Type IV coUagen asscmblcs into a chicken-w irc-
Li ke lattice nctwork that along with lam in in 1-nidogen and pedecan 
(a lso call ed heparan sulfatc proteoglycan) comprisc a largc part of 
the lamina densa. Lamina densa in epiderma l BM is anchored to the 
dermis by anchoring fibri ls in thc sublamina densa regio n . Anchor-
ing fibrils consist of lateraily associatcd dimers of type VII coll agcn. 
Type VII collagen is a homotrimeric protein that contains a small 
noncollagenous domain (N C2) at its carboA,),I-terminaI end. T his 
domain is though t to promote anti parallel dimer f0l111ation by binding 
the sam e domain in another type V II collagen molecuJe. T he amino-
tennin al portion of type VII collagcn contains a large (14S-kD) 
noncolJagenolls do main (NCl) tllat binds type IV collagen in lamina 
densa or anchoring plaques (an lutrastructuraJ anchoring unit in the 
sublamina densa region) . In tlus ImU1ncr, ancholing fibrils cxist as a 
scries oflooping stlUcturaI elemcnts through which intcrstitial collagen 
fibers in thc papilJary dennis may interwcavc. T hese interstitia l 
collagen fibers (along with elastic fibcrs) represent the lowermost 
portions of an adhesive lIlUt that originates in tile cytoskeleton of basal 
keratinocytes and maintains the adhcsion of these celJs to cpidcnna l 
BM and thc papiU,u)' demus. 
COMPONEN TS OF EPIDERMAL BASEMENT MEMBRANE 
Bullous Pemphigoid Antigen 1 (BPAG1) C ircu lating 
anti-BM autoantibo dies fi'om patients with bullous pcmphigoid 
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Figure 1. A schematic model ofhultlan epidermal basement mem-
bralte. In termediate filaments composed of ke ratins 14 and 5 in basal 
keratinocytes inse rt into the electron dense plaqucs of desmosomes and 
hemidesm osomcs; in the latter, they arc tho ught to bind BPAG1. Two other 
constituents of hcmidcsmosomes, BPAG2 and in tegrin cx6 i3., have extracel-
lular domains that extend into the lamina lucida of epidem1al BM at the site 
w here anchoring filaments connect basal kcratinocytes to w1derl ying lamina 
densa. Proteins associated with anchoring fi lam ents include laminin 5, 
laminin 6, epiligrin , and uncein . Other constitucn ts of the lamina lucida 
include laminin 1 and nidogen. T hc lamina densa of epidem1al basement 
m embrane consi sts of a lattice network of structural proteins that includes 
type IV co ll agcn, laminin 1, nidogen , and perlecan . T he lamina densa is 
anchored to the dermis by anchoring fibri ls that consist of latera lly 
associatcd dimers of type VII collagen . Through their associations w ith 
lamina densa and ancho ring plaques in the sublamina densa regio n , 
anchoring fibr il s form a series of looping structural elements through which 
in terstitia l coll agen fibers interweave. Interstitial collagen fibers (collagen 
types I and III ) and elastic fibers (not shown) represent the lowermost 
portio n of an adhesive unit that begins in the cytoskeleton of basal 
keratinocytes. 
have been used to define t\vo target antigens tha t represent 
important structural proteins in basal keratinocytes. When sera 
from bullous pemphigoid patients are mL'Xed with extracts of 
biosynthetically radiol abeled keratinocytes, they immunoprecipi-
tate a 230-kD antigen termed bullous pemphigoid antigen 1 
(BPAG1) or BP230 (mass estimates in soclium dodecylsulfate-
polyacrylamide gel electrophoresis [SDS-PAGE] ranging from 220 
to 240 kD) [1] . Greater than 90% of sera from bullous pemphigoid 
patients immunoprecipitate this protein . BPAG1 has also been 
identified by immunoblotting extracts of no rmal human epidermis 
w ith sera from bullous pemphigoid patients [2,3] . IgG autoantibod-
ies affinity purified against BPAG l immobilized on ni trocellulose 
paper bind epidermal BM in a pattem indistinguishable from that of 
w hole sera from bulJous pemphigoid patien ts [4]. BPAG'! has been 
localized to the plaque of hemidesm osom es in the cytoplasm of 
basal keratinocytes. Consistent with this localization, a portion of 
tlus molecul e has been found in the non-ionic detergent-insoluble 
particulate Ii'action of cultured keratinocytes and epidermis [5]. 
Autoantibodies Ii'om patients with bullous pemplugoid w ere a.lso 
used to isola te cDNA clones encoding BPAG I gene sequences from 
a human keratinocyte expression library [6]. T he partial cDNA for 
this protein was subsequently used to isolate overlapping cDNAs 
encoding the full length of BPAG1. Comparative studies with 
murine BPAG1 cD N A demonstrated 77% identity in corresponding 
regions-a findin g that signifies evolutionary (and probably phys-
iologic) conservation of this protein. Sou thern analysis of genomic 
DNA has shown that BPAG1 is encoded by a single-copy human 
gene [7 ,8] . R elated genes have been detected in mammals but not 
in the genomic DNA of the c1ucken, frog, o r fish [8] . T he gene 
encoding BPAGI has been localized to the short arm of human 
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chromosom e 6 at 6p11 - 6p12 [9]. Northem analysis has detemUned 
that the full-length mRNA encoding BPAG1 is 9 kb; it is expressed 
in kera tinocytes but not fibroblasts or nonstratified squamous 
epithelia [6,7,10], confinning prior immunofluorescence micros-
copy studies showing iliat BPAG 1 is present in normal stra tified 
squamous epithelia and certain complex epithelia (e.g., trachea, 
urinary bladder, gall bladder) , but not simple epithelia or non-
epithelial tissues [10] . In adclition , polyclonal antibodies raised 
against fusio n proteins or synthetic peptides corresponding to the 
carboxyl-terminal region of BPAGl have been shown to bind the 
plaque of henudesmosomes in the cytoplasm of basal keratinocytes 
by immunoelectron microscopy, again confirming prior ultrastruc-
tura l localization studies using autoantiboclies from patients with 
bullous pemphigoid [11]. 
Analysis of the deduced amino acid sequence ofBPAG1 revealed 
its profound sequence a.nd structural homology with desmoplakin 
lI ll and plecwl [12 ,13]. Desmoplakin lIII is a desmosomal plaque 
protein that is thought to play a key role in bineting keratin 
intermediate filaments to desmosom es [14]. Similarly, p lectin is a 
large intracellular protein (466 kD) tllat also binds interm ediate 
fi laments [1 5]. T hese molecules have a central coiled-coil a -helical 
rod domain containing a regular periodicity of aciclic a.nd basic 
amino acid residues. Further analysis has shown that acidic and 
basic residue periodicities are 180 0 o ut of phase, suggesting a 
m echaJusm by w luch these proteins m ay self-aggregate by iOlUC 
interactions. At their carbo,,-)'I termilu, BPAG1, desmoplakin lIll, 
and plectin con tain homologous domains that also clisplay acidic 
and basic amino acids in a regular periodicity. The periodicity of 
these domains is similar to that of the rod domain of keratins and 
may represent a means fo r the iOluc interaction of these proteins 
Witll the cytoskeletal net\Vork of intermediate filaments. The amino 
te rmuu of BPAG1, desmoplakin lIII, aJld plecwl also share se-
quence homology. T hese molecules are thought to fom1 a gene 
family that plays an importan t ro le in maintaining the structural 
integri ty of epithelial cells. 
Bullous Pemphigoid Antigen 2 (BPAG2) Approximately 50% 
of patients with bullous pemphigoid have circulawlg IgG autoan-
tibodies that recognize a lS0-kD keratinocyte proteul in in1l11tlno-
blots of epidennal extracts (m ass estim ates in SDS-PAGE ranging 
from 160 to 180 kD) [3,10] . T his antigen , bullous pemphigoid 
antigen 2 (BPAG2), is recognized by circulating autoaJltiboclies 
from an even higher percentage (e.g., 85 to 90%) of patients with 
herpes gestationis [16] . T he identification of these autoantiboclies 
has in fact served to uni fy m an y of the clinical, histologic, immu-
no pathologic, and pailiophysiologic features of these two acquired 
auto immune subepiderm al bullous cliseases [17]. Autoantibodies 
from tl1ese patients have also detected BPAG2 in immunoprecipi-
tation stuclies of radiolabeled human keratinocyte extracts 
[4,1 8,19], tho ugh results in such stuclies are somewhat inconsistent 
and m ay relate to differences Ul tl1e extraction tecluuques used in 
differen t laboratories or tl1e susceptibility of this protein to prote-
o lysis. 
As in the isolation of cDN As encoding BPAG1 , sera from 
patients w ith autoaJltibodies directed against BPAG2 have been 
used to isolate cDN As encoding tlus protein [20,21]. Northern 
an alys is has shown that dle fu\l-lengtll mRN A 'en coding BPAG2 is 
6 kb in length and hence clearly disWlct from the 9 kb mRNA for 
BPAG1. T he gene encoding BPAG2 has been localized to the long 
arm of chromosome 10 at locus 10q24.3 [22]. Polyclonal antiboclies 
raised against a fusion protein encoded by BPAG2 cDNA localizes 
to hemidesmosom es of basal kerawlOcytes by uldirect immunoelec-
tron llUCroSCOpy [20]. 
Analysis of the deduced anUno acid sequence of BPAG2 shows 
that tlus protein is a transmembrane molecule with a type II 
orientation (i.e., the carbo,,-),I-tenninal portion of tlle molecule is 
extracellular). In addition , the extracellular portion of BPAG2 
consists of 15 collagenous domains of various sizes tllat are 
separated by short no ncollage l1ous sequences [21-23]. T he collag-
eno us domains of BPAG2 are characterized by typical Gly-X-Y 
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Table I. Integrins Expressed by Keratinocytes in Adult 
Human Skin" 
Integrin Ligand(s) 
Collagens, laminjns' 
O',f3 ,/' Lanlinin 5, lalninjn 1 tI 
Laln injn 5, ianlinin 11' 
Localization 
Basal keratinocytes and the first 
1 to 2 suprabasaJ cell layers 
Basal keratinocytes and the fi rst 
1 to 2 supra basa l ce )) layers 
The basilar portion of basal 
keratinocytes (as well as low 
levels of subunjt 0'6 on the 
lateral and apica.! surfaces of 
basal keratinocytcs) 
"Other intcgrins nfC expressed by kcratinocytcs during cpidcnl1al developmen t, 
wound healing. :md in cul ture. Mo reover, some intcgrins sti ch as Cl v f3s (a vitro llcctin 
receptor), Ctsf3 , (a fibro ncctin receptor). Ct6 f3, (a receptor for laminins 1 and 5) . and Q,f31 (a receptor for collagen and laminin) nrc expressed in feta l skin but weakly, if at 
all. in adult human skin . 
b In addition to the ir traditional ro le in cell-matrix in teractions listed here, these 
integrins may ;l Isa pl:ly a ro le in cell- cell intera ctions between kcratinocytcs. Interest-
ingly, in adult epidermis. thesc intcgrins appea r to be conccntr:ltcd at I ... teral and apical 
cell surf:lces. predomina ting in ;Ircas of cell-cell cont;lct (i.n con trast to their uniform 
distribution aTound kcratinocyte plasma membranes in fetal skin) . 
f Primarily a coll agen receptor, though it has afti nity for lami llin 1 in some cells. 
Ii TraditionaUy considered a laluininl receptor. current evidence suggests that its 
greatest affinity is for laminin isoform 5. 
f: Although the specific ligand for this intcgrin has becn a subject of controversy. 
recent experimental fi ndiJlgs suggest that it binds laminin isoforms I and 5. 
seq uences and tl:us mol ecule has been designated as type XVII 
collagen , although it is not known whether BPAG2 is a triple-
helical molecule Hke other collagens. T he extracellular coll agenous 
domains ofBPAG2 are thought to bind proteins in lamina lucida 
and thus promote adhesion of basa l keratinocytes to epidermal BM. 
Several lines of evidence suggest that the major ep itope recognized 
by circulatin g autoantibodies from patients with bullous pemphi-
goid and herpes gesta tionis resides in a segment ofBPAG2 between 
the first extracell ular co lJ agenous domain and the transm embrane 
portion of the mol ecule [24,25] . T he transmembrane dom ain of 
BPAG2 is a single hydrophobic region of 23 amino acids in the 
proxim al one third of this molecule. T he amino-terminal, intracel-
lular portion of BPAG2 is very basic and contains four internal 
hom ologous repeating units of 24 to 26 amino acids. How this or 
other parts of the molecule associate w ith other hemidesmosom e 
constituents is currently unknown. 
Integrins Integrins are heterodim eric transmembrane receptors 
that promote ce ll -ce lJ and celJ-m atrix interactions . Although an 
extensive review of this subj ect is beyond the scope of this 
manuscript, severa l comprehensive articles have recentl y been 
pubHshed [26-30]. Summary comments about in tegriJls are pre-
sented below and the predominant in tegrins expressed on normal, 
adult human keratinocytes are Hsted in Table I . 
All integrins are 0'f3 heterodim ers . Fourteen 0' and eight f3 
subunits have been iden tified ; several of these have alternatively 
spliced cytoplasmic domains (e.g., O'lIb ' 0'3' O'u' f31' and (34) ' 
Although several of the 0' subunits can associate with more than 
one f3 subunit, the re is restriction in the number of heterodimers 
that actually form. Both integrin subunits are transmembrane 
g lycoproteins with a single hydrophobic transmembrane do main 
wi th a short cytoplasmic domain (i.e., 50 amino acids o r less). A 
notable exception to this design is subunit f34' w hich contains a 
cytoplasmic domain of over 1000 amino acids. T he extracellular 
domains of the in tegrin subunits associate to form dimers; subunits 
do not rely on associations of domains in the ir cytoplasmic or 
transm em brane regions to dimeri ze . Both subunits of the he t-
erodimer are required for ligand binding. In fact, 0' and f3 subunits 
are thought to form a pocket that serves as a specific ligand-binding 
site. T hi s hypothesis is consistent with the observation that switch-
ing e ither the 0' o r f3 subuni t can resnlt in changes in Hgand 
specifi city. H owever, individu al iJ1tegrin s can often bind to more 
than one liga nd and, simi1arl y, individual ligands can often be 
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recognized by more than one integrin . Integrins often bind specific 
sequences of peptides in a given group of adhesion molecules (e .g., 
the Arg-Gly-Asp [RGD] sequence present in fibronectin, vitronec-
tin, and other adhesion proteins). Integrin ligand binding is diva-
lent-cation dependent and the cation itself (e.g., Ca ++ , Mg++ , 
Mn + +) can affect the affinity as well as the ligand specificity of the 
integrin. In summary, the amino-terminal domains of 0' and f3 
subunits combine to form a Hgand-binding site on the head of the 
integrin receptor. Tlus Hgand-binding site is connected by contin-
uations of each respective 0' and f3 subunit to their transmembrane 
and cytoplasmic domains . Cytoplasmic domains of integrins are 
thought to interact with cytoskele tal elements (e .g., talin, vinculin, 
actin filaments) and other intracellular components. The cytoplas-
mic domains and associations of integrin 0'6f3" represent an excep-
tion to tlus model in that they are concentrated witlun hemides-
mosomes of epithelial cells, including those in basal keratinocytes 
[31-33] . 
By virtue of its localization in hemidesmosom es of basal kerati-
nocytes, integrin O'uf34 is associated with the keratin intermediate 
filament cytoskeleton of these epithelial cells (rather than the actin 
cytoskeleton as true for most other integrin receptors). The 0'6 
subunit exis ts in two distinct forms, A and B. The former is the 
predominant subunit found in keratinocytes. Although it is not 
known whether integrin 0'6 f34 is associated with BPAG1 and/or 
BPAG2 in hemidesmosomes of basal keratinocytes, its extracellular 
domain is considered an important receptor for adhesion ligands in 
the lamina lucida of human epidennal BM (see below) . For some 
time the Hgand specificity of integrin O'uf3" was controversial, 
though laminin 1 was regarded as a likely candidate. R ecently, 
Niessen et al estabHshed stable transfectants in the K562 human 
erythroleukemic cell line that express integrins 0'6A f34 and O'uBf34 
[34] . U sing these stable transfectants, these investigators showed 
that laminin type 5 (i .e., kalinin, nicein) and laminin type 1 (i.e ., 
"classical" or EHS laminin) are Hgands for tlus integrin receptor. 
The localization of these laminin isofonns within human epidermal 
BM (especially, that oflaminin 5 to anchoring filaments, see below) 
make them prime candidate Hgands for integrin O'uf34 in basal 
keratinocytes . 
Larninin 1 Laminin 1 is a non-colJagenous protein that is con-
sidered a ubiquitous component of epitheHal BMs. It w as llutially 
isolated from the transplantable mouse Engelbreth-Holm-Swann 
(EHS) tumor and hence designated EHS laminin or classicallaminin 
[35,36]. Laminlll 1 is a multidomain protein of - 800 kD that is 
composed of three genetically distinct polypeptide subunits referred 
to as the 0'1 subunit (- 400 kD, formerly ca lJed the A or Ae chain 
[the latter, in reference to the A chain of "E"HS laminin]), the f31 
subunit (- 220 kD, fonnerly called the B1 or B1e chain), and ')'1 
(~210 kD; formerly calJed the B2 or B2e chain). 
By rotary-shadowing electron microscopy, laminin 1 has the 
shape of an asymmetric cross with three short arms (two of - 34 
nm, one of - 48 nm) and one long arm (- 77 11m) [37,38]. The 0'1, 
f31, and ')'1 chains of lamll,in have a very simi1ar structure of six 
primary domains. In brief, domains I and II are composed of heptad 
repeats that contribute to a triple coi1ed-coi1 ex belical confirmation 
of the long arm ; domains III and V have cysteine- and glycllle-rich 
repeats with considerable homology to epidermal growth factor; 
finally , domains IV and VI comprise globular portions of the 
m olecule. In addition, the 0'1 chain has a large globular segment at 
the carboxyl-terminal end of domain I that accounts for - 25% of 
th e mass of tlus particular polypeptide. Tlus globular segment of 
laminin subUlut 0'1 is also called the "foot" of the molecule and 
consists of five "toes" that contain repeat sequences rich in basic 
amino acid residues. The overall structure of laminin 1 is stabilized 
by interchain disulfide bonds as well as other associations such as 
the triple coiled-coil 0' helix formed between domains I and II of 
0'1, f31, and ')'1 subunits. T his model is cO l1sidered a prototype for 
othe r lamllun isoforms (see below). 
The diverse biologic fUIl ctions that lamuun 1 elicits from celJs are 
largely mediated via its interact\ons with integrin receptors [35,38-
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40]. A major integrin receptor binding site is located toward the end 
of the long arm of laminin 1. This particular site is recognized by 
integrin a 6 {3, (or in a few cells by integrin a 7 {3 ,) . A minor 
cell-binding site has also been localized to the two most carboxyl-
terminal g lobules of the 0' chain. Additional cellular interactions 
occur between in tegrin receptor 0: , {3, and the center of the cross 
formed by the lam inin 1 short arms; after partial proteolytic 
cleavage of laminin 1, RGD-dependent integrins aJso bind this 
sam e portion of the molecule. Important biologic responses that 
laminin 1 promotes include adhesion , differentiation, migration, 
and morphogenesis. 
In addition to its biologic functions, laminill 1 is a structuraJ 
component of epithelial BMs. As stated earlier, nidogen binds with 
high afrlnity to a specific cystein e-l;ch repeat of domain III in 
laminin subunit -yl and connects this matrL'i: molecule to the highly 
cross-Linked network structure of type IV collagen in BMs [41] . 
The laminin-nidogen complex can also bind to the core protein of 
heparan sulfate proteoglycan. In addition, it has recently been 
demonstrated that in the presence of Ca + + , laminin 1 molecules 
can self-assemble ;/1 1/ ;11'0 into a network structure-observations 
that have raised the hypothesis that independent network structures 
of laminin 1 and type IV collagen may exist in BMs and be 
interconnected by smaller m olecules such as nidogen [42]. It has 
also been suggested that the expression of matrix proteins in such 
networks may be developmentally regulated with laminin 1 COI11-
prising the scaffold that promotes morp hogenesis of BMs whereas 
type IV collagen in mature BMs provides greater tensile strength 
and stability. 
R ecently, it has been demonstrated that laminin is not a single 
molecul e but rather a fall'lily of heterotrimeric isoforms that are 
loca lized in a tissue-specific distl'ibution [35] . At present, there are 
eight (or perhaps nine) known laminin subunits, and seven identi-
fied heterotrimeric laminin isoforms. In addition to laminin 1, 
recent studies have shown that two other laminin isoforms ex;st in 
adult human epidermal BM. These isoforms, larrinins 5 and 6 (as 
well as laminin 7 in fetal skin), are thought to display important 
structural and biologic functiollS in human skin. 
Laminin 5 Laminin 5 (aJso called kalinin or nicein) is a recently 
identifi ed laminin isoform that is present in BMs of stratified 
epithe lia in skin , trachea, esophagus, COl'l1ea, amnion, and (in small 
amounts) the gastrointestinal tract [43 ,44]. In human epidermal 
BM, laminin 5 hilS been loca lized to anchoring filaments. This 
molecule is targeted by autoantibodies in patients with a form of 
cicatricial pemphigoid and mutated in individuals with Herlitz's 
junctional epidermolysis bullosa (H-JEB) [45-48]. Blisters form in 
the lamina lucida in both of these conditions . 
La minin 5 consists of disulfide-linked 0'3, {33, and -y2 subunits. 
These subunits (like those found in other laminin isofonns) show 
homo logy to corresponding subunits in "classical" laminin 1. T he 
synthesis and processing of laminin 5 in human keratinocytes has 
been recently characte,;zed [44,48]. Lal11i nin subunit 0:3 exists as a 
cell-associated precursor of 200 kD that is rap idly processed 
following secretion to a 165-kD polypeptide. In comparison to 
laminin subunit 0'1, 0'3 is truncated, lacks the ami,no-terminal 
domains, and contains a G domain of reduced size. T hese extensive 
shortenings within 0'3 make it the laminin 5 subunit with the least 
homology to analogous chains in laminin 1. Laminin subw'lit 0:3 
shows stru ctural and immunologic similarity to the 0: subunit of 
laminin 6 (also called K-Iaminin, see below). Like laminin subunit 
a3, laminin subunit -y2 exists in two fonns-a 155-kD cell-
associated form and a processed 105-kD polypeptide. The complete 
nucleotide sequence of laminin subunit -y2 shows approximately 
50% homology to laminin subunit 1'1 [49] but, compared to laminin 
subunit -y1, several domains in this polypeptide are significantly 
truncated (specifically, domains I, n, nI, IV, and V), whereas 
domain VI is absent. In te restingly, it has been hypothesized th at 
lamlniJJ 5 in tissue relies upon a cova lent association with laminin 6 
(rather than binding to nidogen) for the basis of its linkage to type 
IV collagen in lamina densa (see below). Finally, laminin subunit {33 
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exists as a 140-kD homologue oflaminin subunit {31 that does not 
undergo processing following secretion. Most truncations in this 
subunit are localized within its short arm, with the lon g arm 
showing substantial identity to laminin subunit {31. Laminin 5 in 
tissue is currently thought to most closely resemble the fully 
processed form oftbe heterotril11er (i.e., disulfide linked subunits of 
165,140, and 105 kD) [44]. 
Nicein (also called BM600) is a large protein initially recognized 
as a constituent of epidermal and amnion BMs [50,51]. Monoclonal 
antibody GB3, used to detect this protein in the lamina lucida of 
norm al epidermal BM, does not bind to the skin of patients w;th 
H-JEB, suggestin g tl1at this protein is specifica.lly impaired in 
patients with tlus disease (see below) [52,53]. Subsequent studies of 
kalinlll showed that it has the same size and tissue distribution and 
is aJso absent fI'om the skin of patients w ith H-JEB [46]. Recently, 
a rigorous study conclusively demonstrated tllat tucein and ka.linin 
are the same protein [47]; this protein is currently designated as 
laminin isoform 5. 
Lamlllin 5 is extensively deposited upon the culture substrate of 
growing and migrating human keratinocytes and \vill promote the 
adhesion of a large number of normal and established cell lines 
[43,54]. It is a better substrate than the complex of iamitun 
1 -tudogen for promoting the adhesion of epitheliaJ cells, including 
that of human kerabJlOcytes. Antibodies against laminin 5 block 
adhesion of cultured human keraonocytes, detach established col-
onies of these cells from their extracellular matrix, and cause 
separation of epidermis from epidermal BM of skin sections ;11 I/;tro 
[43,54]-observations suggesting that laminin 5 plays an important 
role in attachin g keratinocytes to epidennal BM. Moreover, recent 
experimental evidence indicates that integrin receptors a J {3, and 
o:(,{3, specifically bind laminin 5 [54]. Hence, like laminin 1, this 
laminin isoform represents a structural component of epidermaJ BM 
(i.e., a compon ent of an choring filaments) that binds integrin 
receptors (and potentially other molecules) on basal keraonocytes. 
Lam.inin 6 Laminin 6 (aJso called K-lal11ll1in) is a recently 
identified laminin isoform whose distribution in hW11an tissues 
appears to coincide with tl1at of laminin 5 (i.e., BMs of epidemus, 
trachea, esop hagus, anmion, and the gastrointestinaJ tract) [55]. It is 
not present in n on- epithelial BMs of pet;pheral nerve, skeletal 
muscle, o r blood vessels. Laminin 6 is produced by humaJl and 
bovine kerabJl0cytes, the squamous cell carcinoma line SCC-25, 
and cultured skin explants; it is also present in at11luotic fluid. The 
subunit composition of laminin 6 is a?{31 -yl (i.e., an incompletely 
characterized 0: subunit and (3 and -y subunits that are also found in 
lamitun 1). T hough incompletely characterized, the 0: subunit of 
laminin 6 is known to be a 190-kD polypeptide that shows 
structural and immunologic simil arity to the 0' subuni t of lamiuin 5 
[48,55]. Preliminary evidence suggests that, in tissue, laminins 5 
and 6 are joiried as a disulfide bonded complex that binds to cells 
via domallls in laminin 5 and is connected to type IV collagen in 
lamina densa via nidogen bound to the -yl subunit of lamllun 6 
[44,48]. T lus model accounts fo r the parallel tissue distribution of 
these laminin isofol'l11S and also explains how laminin 5 may be 
linked to lamina densa despite the f.1Ct it has a truncated I' subunit 
with a low afrlnity for nidogen. 
Epiligrin Epiligrin is a glycoprotein complex originally identified 
in the extracellular matrix of cultured human keratinocytes [56]. 
T lus complex was named epiligrin to denote its activity as the major 
integrin ligand of human epidermal cells. 1/1 ,,;tro, epiligrin has been 
shown to bind integrin a3 {3, on human keratinocytes and co-
localize with illtegt'in a 6 {34 in hemidesl11osome-like stable anchor-
ing complexes [56,57]. Epiligrin h as been localized to the lamina 
lucida of normal human epiderma l BM and, like laminin 5, has been 
show n to be absent from the skin of patients with H-JEB [45] . 
Recently, R yan ef til reported that this integrin ligand is a lanlinin 
isofonn [58]. T hese investigators isolated at least two diSbJlct 
cDN A clones corresponding to the a subuni t of epiligrin (0:3 EpA 
and 0:3 EpU); they also identified a genomic clone corresponding to 
tlle a3 Ep gene (LamA3). At present, there is general agreement that 
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1) epiligrin and laminin 5 are probably identical [58] ; 2) the ex 
subunit of these proteins is targeted by IgG anti-BM autoantibodies 
in patients with a form of cicatricial pemphigoid [45]; and 3) there 
is immunologic crossreactivity between the ex chains of epiligrin, 
laminin 5, and laminin 6. How the different epiligrin ex chain 
variants are specifically related to ex subunits in lamillins 5, 6, and 7 
awaits sequencing of the latter. 
BASEMENT MEMBRANE COMPONENTS AS 
TARGETS OF DISEASE 
Bullous Pemphigoid and Herpes Gestationis Virtually all 
patients with bullous pemphigoid (including patients with variants 
such as localized, childhood, or vesicular bullous pemphigoid) have 
circulating IgG anti-BM autoantibodies directed against BPAG1; 
approximately 50'Vo have circulating autoantibodies to BPAG2 
[1 ,3,10,18,59,60]. In herpes gestationis, IgG anti-BM autoantibod-
ies are primarily directed against BPAG2 [16,20]. Currently, it is not 
understood how circulating autoantibodies directed against an 
in.tracellular protein (i. e., BPAGl in the hemidesmosomes of basal 
keratinocytes) contribute to the pathogenesis of these blistering 
diseases. Moreover, attempts to produce an animal model by 
passively transferring purified IgG from patients with bullous 
pemphigoid to experimental animals have fai led [61 ,62]. However, 
recent studies by Hall and co-workers have shown that ultraviolet 
irradiation of rabbits that possess high titers of circulating autoan-
tibodies directed against BPAG1 (secondary to immunizations with 
synthetic pep tides corresponding to portions of this molecule) 
produces epidermal necrosis and immunoreactant deposition at 
exposed sites [63). Although there are several differences between 
tlus animal model and bullous pemplugoid (i.e., epidermal necrosis 
rather than blister formation, immunoreactant deposition in epider-
mal BM following, not preceding, skin lesions) , these experimental 
observations demonstrate that circulating antibodies di.rected 
against BPAG1 can lead to an enhan ced inflammatory response 
folJowing injury to rabbit epidennis. Perhaps injury of basal kera-
tinocytes in patients with bullous pemphigoid results in exposure of 
BPAG1 to circulating autoantibodies that subsequently bind anti-
gen, fix complement, and generate an inflammatory infiltrate that 
results in blister formation. However, tlus model does not explain 
how at;toantibodies direct~d against BPAG1 form in the first place 
or how they produce lesions in the absence of injury to basal 
keratinocytes. Such questions have led to the idea that anti-BPAG1 
autoantibodies .may be formed as a conseq uence of keratinocyte 
injury initiated by autoantibodies directed against BPAG2. Relat-
edly, the intracellular localization of BPAG1 may explain why 
autoantibodies directed against this antigen predominate in these 
pati.ents' circulation because they do not have access to "exposed" 
antigen ;,t vivo under nonnal circumstances . 
BPAG2 has an extracellular domain that is regarded as a prime 
candidate for exhibiting pathogenic epitopes in patients with bul-
lous pemplugoid and herpes gestationis. Indeed, epitope mapping 
has shown that circu latin g autoantibodies from these patients bind 
a common antigenic site within the major noncoLlagenous portion 
of BPAG2 ectodomain [24]. This immunodominant epitope is 
located between the transmembrane and first collagenous repeat of 
BPAG2, a portion of the molecule that shows an unu sually high 
degree of sequence divergence with murine BPAG2. Tlus diver-
gence was thought to possibly explain why prior attempts to 
produce an alumal model of bullous pemplugoid by passively 
transferring autoantibodies from patients with this disease (i.e., IgG 
directed against human BPAG2) to neonatal mice (i.e., subjects 
expressing the mismatched murine BPAG2) tailed. Building on tl~s 
hypothesis, Liu and co-workers recently immunized rabbits with a 
recombinant form of murine BPAG2 that corresponds to the 
homologous immunodominant epitope of human BPAG2 [25]. 
Passive transfer of purified rabbit antibodies directed against tlus 
portion of murine BPAG2 into neonatal mice induced a blistering 
reaction that mimics bullous pemplugoid and herpes gestationis 
clinically, histo logically, and immunopathologically. Subsequent 
passive transfer studies in C5-deficient neonatal mice have shown 
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Table II. Adhesion Molecules as Targets of Disease" 
AutoirnnlUIlC Genetic Protein Structural 
Disease Disease Target Target 
BuUous pemphigoid; ?/, llPAGl Hemidesmosomes 
herpes gestationis llPAG2 
C icatricial pemphigoid' Herlitz's Lalninin 5 Anchoring 
JEll"'" filaments 
E pidermolysis bullosa DEll" Type VII Anchoring 
acquisita coHagen fibrils 
(I Impairments of adhesion mol ecules induced by either autoantibodies or specific 
I"tlUtacions may produce bullous diseases with a similar phenotype. Moreover. in other 
bullolls diseases. diHcrcnt adhesion lllolccu1cs o r structural proteins arc targeted by 
autoantibod ies (e.g., dcsll10glcin I in pemphigus roliaccus, dcsmoglcin 3 in pClnp~tigus 
vulgaris, dcslllopiakins 1111 in parallcoplastic pemphigus) or l11utntiol1s (e .g., keratin 14 
Or keratin 5 in epidermolysis bullosa simplex). 
II Sec text for details. 
(' Autoantibodies directed against lal11inin 5/epiUgrin represcnt a specifi c marker for 
certain patients with cicatricial pcmphigoid. Other patients with the same c1iuical 
phenotype have autoantibodies directed against oth er target antigens in epidermal 
basement membrane. 
" JEll and DEll refer to junctional and dystrophic forms of epidermolysis bullo,a, 
respectively. 
that blister formation in tlus model is complement dependent [Liu 
Z, Diaz LA, Swartz SJ, Taylor AF, Emery-DJ, TrotJL, Fairley JA, 
Giudice GJ: Defining the animal model of bullous pemplugoid and 
herpes gestationis by passive transfer of anti-BP antibodies (abstr). 
J Jrwesl Derlllalol102:558, 1994]. This experimental model provides 
further support for the hypothesis that autoantibodies directed 
against BPAG2 are pathogeluc (Table II). This model wilJ hope-
fully lead to a greater understanding of the immunologic and 
biologic mechanisms of disease in patients with bullous pemphigoid 
and herpes gestationis, and also provide a way to test new therapies 
for these autoimmune diseases. 
Generalized Atrophic Benign Epidertnolysis Bullosa 
(GABEB) GABEB is an autosomal recessive form ofJEB charac-
terized by subepidennal blisters of skin and mucous membranes, 
onychodystrophy, defects in dental enamel, "atrophic alopecia," 
and giant melanocytic nevi that form at sites of prior bullous lesions 
[64]. By transnUssion electron nucroscopy, hemidesmosomes in 
basal keratinocytes of these patients' skin have been shown to be 
absent or rudimentary [64]. Recent studies have shown that the 
expression ofBPAG2 is diminished in the epidennal BM of patients 
with GABEB Donkman MF, de Jong MCJM, H eeres K, Pas HH, 
Bruins S, van der Meer JB , Niessen CM, Sonnenberg A: 180-kO 
bullous pemplugoid antigen (BPAG2) is not expressed in general-
ized atrophic benign epidermolysis buLlosa (abstr).] Illvesl Derlllatol 
102:609, 1994; and Pohla-Gubo G, Lazarova Z, Giudice G, Liebert 
M, Grassegger A, Hintner H, Yancey KB: Diminished expression 
of the extracellular domain of bullous pemplugoid antigen 2 
(BPAG2) in the epidermal basement membrane of patients with 
generalized atrophic benign junctional epidermolysis buUosa (ab-
str). elil! Res 42:454,1994] . Moreover, unlike patients with H-JEB 
(see below), laminin 5 has been shown to be present in the 
epidermal BM of GABEB patients [Pohla-Gubo G, Lazarova Z, 
Giudice G, Grassegger A, Hintner H, Yancey KB: The nicein! 
epiligrin!kalinin (NEK) complex and related adhesion molecules 
<lre present in the epidermal basement membrane of patients with 
generalized atrophic benign junctional epidermolysis buUosa (ab-
str) . ] I,wesl Dermalol 102:562, 1994] . Whether decreased expres-
sion of BPAG2 represents the primary defect in patients with 
GABEB is not known. However, tlus fmding represents another 
e"ample where an important adhesion mol ecule in human skin 
(i.e., BPAG2) is targeted by autoantibodies in patients with an 
<lcquired autoimmune bullous disease and expressed defectively in 
patients with an inherited bulJous disease (Table II). It is interest-
ing to note that recent studies by McGrath e/ al have identified 
mutations in the {33 subunit oflamilun 5 in a family containing three 
members affected with a variant of JEB that resembles GABEB 
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(McGrath JA, Pulkkinen L, Christiano AM, Burgeson RE, Leigh 
1M, Eady RAJ, Uitto J: Mutations in the LAMB3 gene in the 
generalized atrophic form of junctional epidermolysis bullosa (ab-
str). ] [,west Derma/ol 103:434, 1994]. In this family, mutations 
involved domain VI of the (33 subunit-a globular domain of the 
protein thought to playa critical role in the interaction of laminin 
5 with other matrix proteins (e.g., laminin 6). These findings raise 
interesting questions regarding structural and functional correlates 
of laminin 5 (and relatedly questions about how mutations in this 
molecule may result in different disease phenotypes, see below). 
Such findings in a single family do not exclude the possibility that 
mutations in other adhesion molecules (e.g., BPAG2, uncein) may 
result in a similar disease phenotype. 
Cicatricial Pemphigoid Patients with cicatricial pemphigoid 
characteristically have deposits of immunoglobulins (usually IgG 
and/ or IgA) and complement components in their epithelial BMs; 
direct immunoelectron microscopy has shown that such deposits 
are localized in the lamina lucida and along the lamina densa of 
e pidermal or mu cosal BMs [65 ,66]. Although some patients with 
cicatricial pemphigoid have circulating autoantibodies directed 
against epidermal BM, they are usually of low titer and it has been 
difficult to define their target antigen using standard immuno-
chemical teclmiques (e.g., immunoprecipitation or immunoblot-
ring) [67]. 
Recently, a group of patients with cicatricial pemphigoid have 
been identified who have IgG autoantibodies directed against the 
dermal side of1 M NaCI split skin [45 ,68]. These patients' anti-BM 
autoantibodies immunoprecipitate a set of disulfide-linked kerati-
nocyte polypeptides that co-migrate in SDS-PAGE with the same 
complex recognized by monoclonal antibodies directed against 
epiligrin or lami.nin 5. Kirtschig e/ al have recen tly shown that 
circulating IgG fr0111 fiv e of five patients with anti-epiligrlll autoan-
tibodies specifically bind Jaminin subunit ex3 and that sera from 
patients with other blistering diseases (including patients with 
cicatricial pemphigoid who have IgG autoantibodies directed 
against the epidermal side of1 M NaCI split skin) show no evidence 
of reactivity to any subunits of this laminin isoform [Kirtschig G, 
Marinkovich MP, Burgeson RE, Yancey KB: Sera from cicatricial 
pemphigoid patients with anti-epiligrin autoantibodies immunoblot 
the 165 kD subunit of kalinin . ] [,,,,est Dermntol 102:558, 1994] . 
.Anti-BM autoantibodies directed against laminin subunit ex3 are a 
specific marker for patients with this form of cicatricial pemphigoid . 
These finditlgs correlate with prior reports showing that monoclo-
nal antibody BM165 directed against laminul subunit 0'3 indu ces 
d etachment of hUl;lan ·keratinocytes from extracellular matrix as 
well as separation of epidermis from epidermal BM i'l Il ill'o [43]. 
Together, these observations suggest that the cd subunit oflaminin 
5 mediates attachment of basal keratinocytes to epidermal BM and 
thaC autoantibodies directed against it may be pathogenic. 
lIerlitz's Junctional Epidermolysis BulIosa (H-JEB) The 
generalized Herlitz's variant (gravis) is the most severe form ofJEB. 
In many cases, H-JEB is f.'lta l early in life. In 1985, Kennedy e/ al 
reported that the polyclonal antibody AA3 (6/2 antiserum), raised 
against an extract of human amnion, showed diminished reactivity 
to the epidermal BM of patients with H-JEB [69] . Using a similar 
approach, other investigators prepared a series of monoclonal 
antibodies agalllst human amnion and tested them for their utility as 
diagnostic reagents [50]. Of tlus group of probes, monoclona] 
a.ntibody GB3 showed the greatest reduction in reactivity (i.e., no 
or minimal reactivity) against the epidermal BM of H-JEB patients 
[52,53] . Subsequent studies showed that monoclonal antibody GB3 
recognizes a keratinocyte-derived heterotrimer called BM600 Or 
nicein [51,53]-a protein recently shown to be identical to laminin 
5 [47]. As mentioned earlier, this protelll is closely related to 
epiligrin, the major integrlll ligand of huma.n epidermal cells. The 
failure of antibodies directed against laminlll 5 to bind the epider_ 
mal BM of patients with H-JEB made tlus prote in a prime disease 
gene candidate for H-JEB. Additional support for this hypotllesis 
was developed in studies showing 1) that keratinocytes from H-JEB 
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patients attach poorly to tissue-culture substrate and fail to deposit 
normal amounts of inID1Unologically detectable Jamlllin 5 ill tlleir 
extracellular matrix [53]; and 2) that monoclonal anti-Iam.i.nin 5 
antibody BM165 impairs keratinocyte adhesion and promotes 
separation of epidermis from skin sections ill Il itro [43] . Further-
more, several recent investigations have identified laminin 5 gene 
defects in H-JEB patients [70-72]. One study linked the H-JEB 
disease phenotype in foul' families to the gene encoding laminin 
subunit ')'2 [70]. Specific abnormalities subsequently demonstrated 
in the lamlllin ')'2 gene of these and other patients include a 
homozygous point mutation leading to a premature stop codon, a 
homozygous splice site mutation, and a heterozygous deletion-
ulsertion resultlllg in a premature termlllation codon UI one allele 
(the putative mutation in the other allele not yet discovered) 
[70,71]. In four other H-JEB families, linkage to laminin subunit ')'2 
has been excluded-an observation suggesting that a defect in 
laminin subunit ex3, lami.nin subunit (33, or some other structural 
protein in epidernlal BM is responsible for the same disease 
phenotype in other families . Using immunochemistry, Northern 
blottlllg, and protein analysis, Baudolll e/ al have in fact recently 
demonstrated defective synthesis of one of tile lamllun 5 subunits III 
six cases ofH-JEB from five different consanguineous families [72]. 
Disease correlates in these patients itJclude impaired synthesis of the 
')'2 subunit in two patients, of the (33 subunit in three, and of the ex3 
SUbWlit in one-findings supporting the idea that tlus disease phe-
notype may result from mutations in genes encodulg different 
lamulin 5 subunits. Studies attempting to link specific protelll 
impairments with genes encoding lamllIin 5 subuluts (as described 
above for the ')'2 subunit) are in progress. 
CONCLUSIONS 
Epidermal BM is an lll1portant and dynamic structll1'al and fW1C-
tionalunit in human skin. Interactions between adhesion molecules 
i.n epidermal BM form and reform with frequency. In addition, 
these adhesion molecules are thought to provide important signals 
that modulate biologic responses in keratlllocytes. Study of adhe-
sion molecules i.n epidermal BM as well as the signals that they 
provide to keratinocytes will hopefully furtller our understanding of 
cutaneous biology and lead to the development of novel therapies 
for patients with acquired and inherited skin diseases. 
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